Dolby Laboratories

DLB Industrials Specialty Business Services

Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.

Revenue
−3.34%
EPS
−37.5%
Free cash flow
+157.4%

Quarter to June 2026, against a year earlier

64.77 1.45 +2.29%
Market cap
$5.9B
P/E
26.7×
Fwd P/E
20.0×
Dividend yield
2.26%
F-score
6/9
Altman Z
9.17
Beneish M
−2.80
Dividend safety
85/100

Dolby Laboratories (DLB) EBITDA

Alert me on EBITDA

Dolby Laboratories's EBITDA for fiscal 2025 was $363.6M, up 6.08% from $342.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was $342.4M. Over the past ten years it has ranged from $267.3M (fiscal 2018) to $458.5M (fiscal 2021); the current reading is higher than 91% of that period. Dolby Laboratories ranks 13th of 36 Specialty Business Services companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $363.6M 6.08%
FY2024 $342.7M 10.41%
FY2023 $310.4M (0.40%)
FY2022 $311.7M (32.03%)
FY2021 $458.5M 38.35%
FY2020 $331.4M (3.25%)
FY2019 $342.6M 28.17%
FY2018 $267.3M (20.03%)
FY2017 $334.2M 4.19%
FY2016 $320.8M 10.03%

Quarterly newest first

Period EBITDA Change
Jun 2026 $59.4M (57.52%)
Mar 2026 $139.8M 57.12%
Dec 2025 $89.0M 64.00%
Sep 2025 $54.3M (24.69%)
42 more quarters

Against its own ten years

Low $267.3M High $458.5M
Ten-year median $331.4M
Current reading's percentile 91

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on DLB